September 15, 2021 12:01 AM Eastern Daylight Time

BUSINESS WIRE

CureApp高血压治疗App：2021 ESC大会发布在知名心血管期刊《欧洲心脏杂志》上发表的临床试验结果

Opens in new window

Download

Full Size JPEG, 1829x471, 202.0 KB
Small JPEG, 480x124, 35.6 KB
Preview JPEG, 144x37, 5.9 KB
Thumbnail JPEG, 120x31, 4.8 KB

Smart Multimedia Gallery

Overview of the digital therapeutic intervention (HERB system) for essential hypertension. (Graphic: Business Wire)

Overview of the digital therapeutic intervention (HERB system) for essential hypertension. (Graphic: Business Wire)

View and Share Photo

Fig 1. Summary of variation from baseline (adjusted mean, 95% confidence interval) and between-group differences in ABPM, home blood pressure, and office blood pressure while sitting at rest at 12 weeks after enrollment (Graphic: Business Wire)

Fig 1. Summary of variation from baseline (adjusted mean, 95% confidence interval) and between-group differences in ABPM, home blood pressure, and office blood pressure while sitting at rest at 12 weeks after enrollment (Graphic: Business Wire)

View and Share Photo

http://www.businesswire.it/multimedia/it/20210914006252/zh-CN/5047244/

View and Share Logo

Share

Email

All News | News with Multimedia > Press Release: CureApp高血压治疗App：2021 ESC大会发布在知名心血管期刊《欧洲心脏杂志》上发表...